Diabetes Clinical Trials in Nashville

Showing 221-240 of 613 trials

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

NCT02691247

This clinical trial will explore the safety and effect of autologous ex vivo expanded polyclonal regulatory T-cells on beta cell function in patients, aged 8 to 17, with recent onset T1DM. Other measures of diabetes severity and the autoimmune response underlying T1DM will also be explored. Eligible subjects will receive a single infusion of CLBS03 (high or low dose) or placebo.

Diabetes Mellitus

Lisata Therapeutics, Inc.113 participantsStarted Feb 2016

San Diego, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

NCT02580877

The study is a 2 arm, multi-center, randomized, open-labeled clinical trial designed to assess the effects of varying doses and schedules of oral insulin on immunological and metabolic markers in relatives at risk for type 1 diabetes (T1D).

Type 1 Diabetes

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)92 participantsStarted Jan 2016

San Francisco, California, United States • Stanford, California, United States • Aurora, Colorado, United States +16 more locations

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)

Diabetes Trials in Other Cities

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

Glargine U300 Hospital Trial

Day and Night Closed-loop in Young People With Type 1 Diabetes

Rituximab in New Onset Type 1 Diabetes

Type 1 Diabetes and the Brain in Children

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Other Conditions in Nashville